Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas-Reference-Cited by-同舟云学术

Grade scoring system reveals distinct molecular subtypes and identifies KIF20A as a novel biomarker for predicting temozolomide treatment efficiency in gliomas

Published:2023-05-29 Issue:12 Volume:149 Page:9857-9876
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Ye Liguo,Tong Shi’ao,Wang Yaning,Wang Yu,Ma Wenbin

Funder

Beijing Municipal Natural Science Foundation

National High Level Hospital Clinical Research Funding

Tsinghua University-Peking Union Medical College Hospital Initiative Scientific Research Program

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-023-04898-6.pdf

Reference35 articles.

1. Babu D, Mudiraj A, Yadav N, Chandrashekhar YBVK, Panigrahi M, Prakash Babu P (2021) Rabeprazole has efficacy per se and reduces resistance to temozolomide in glioma via EMT inhibition. Cell Oncol (Dordrecht). https://doi.org/10.1007/s13402-021-00609-w

2. Barthel L, Hadamitzky M, Dammann P, Schedlowski M, Sure U, Thakur BK, Hetze S (2022) Glioma: molecular signature and crossroads with tumor microenvironment. Cancer Metastasis Rev. https://doi.org/10.1007/s10555-021-09997-9

3. Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A et al (2013) Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. https://doi.org/10.1016/j.immuni.2013.10.003

4. Chen B, Khodadoust MS, Liu CL, Newman AM, Alizadeh AA (2018) Profiling Tumor Infiltrating Immune Cells with CIBERSORT. Methods Mol Biol (Clifton, NJ). https://doi.org/10.1007/978-1-4939-7493-1_12

5. Chen Y-H, Hueng D-Y, Tsai W-C (2018a) Proteolipid protein 2 overexpression indicates aggressive tumor behavior and adverse prognosis in human gliomas. Int J Mol Sci. https://doi.org/10.3390/ijms19113353